Benaim Ely
- SEC CIK
- 0001632237
No open-market purchases or sales filed in the past year.
Current role at each company
- NVCR NovoCure LtdChief Medical Officeras of Jan 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Benaim Ely as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 (view filing) | Aug 3 | 1 day | Benaim ElyChief Medical Officer | SSale | −5.96K | $73.73 | −$439.3K | −17.2%28.7K after | 2 lots |
| Aug 3, 2022 (view filing) | Aug 2 | 1 day | Benaim ElyChief Medical Officer | SSale | −437 | $69.66 | −$30.4K | −1.2%34.6K after | |
| May 12, 2022 (view filing) | May 10-11 | 2 days | Benaim ElyChief Medical Officer | SSale | −4.21K | $63.17 | −$265.6K | −10.8%34.8K after | 2 lots |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Benaim ElyChief Medical Officer | SSale | −2.31K | $71.83 | −$166.1K | −5.1%43.3K after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Benaim ElyChief Medical Officer | SSale | −464 | $150.11 | −$69.7K | −1.6%28.1K after | |
| Aug 3, 2021 (view filing) | Jul 30-Aug 2 | 4 days | Benaim ElyChief Medical Officer | SSale | −1.19K | $154.63 | −$183.6K | −4.0%28.6K after | 2 lots |